Preferred Name |
Inosine Pranobex |
|
Synonyms |
|
|
Definitions |
A formulation containing inosine, 4-acetamidobenzoic Acid, and N,N-dimethylaminoisopropanol, with immunomodulatory and antiviral activities. Although the exact mechanism of action is unknown, inosine pranobex appears to act as a thymus hormone analog; following administration, this agent may both induce T-cell differentiation and potentiate lymphoproliferative responses against transformed or virally-infected cells. |
|
ID |
http://purl.obolibrary.org/obo/NCIT_C601 |
|
CAS_Registry |
36703-88-5 |
|
Chemical_Formula |
C10H12N4O5.3C9H9NO3.3C5H13NO |
|
code |
C601 |
|
Contributing_Source |
FDA |
|
definition |
A formulation containing inosine, 4-acetamidobenzoic Acid, and N,N-dimethylaminoisopropanol, with immunomodulatory and antiviral activities. Although the exact mechanism of action is unknown, inosine pranobex appears to act as a thymus hormone analog; following administration, this agent may both induce T-cell differentiation and potentiate lymphoproliferative responses against transformed or virally-infected cells. |
|
FDA_UNII_Code |
W1SO0V223F |
|
in_subset |
http://purl.obolibrary.org/obo/NCIT_C63923 |
|
label |
Inosine Pranobex |
|
Legacy Concept Name |
Inosine_Pranobex |
|
NCI_Drug_Dictionary_ID |
39487 |
|
PDQ_Closed_Trial_Search_ID |
39487 |
|
PDQ_Open_Trial_Search_ID |
39487 |
|
Preferred_Name |
Inosine Pranobex |
|
prefixIRI |
NCIT:C601 |
|
prefLabel |
Inosine Pranobex |
|
Semantic_Type |
Pharmacologic Substance Nucleic Acid, Nucleoside, or Nucleotide |
|
UMLS_CUI |
C0022230 |
|
subClassOf |